Related Experiment Video
Updated: Jan 4, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
Alterations of the Gut Microbiota in Multiple System Atrophy Patients
Linlin Wan1, Xin Zhou1, Chunrong Wang1
1Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.
Abstract:
Multiple system atrophy (MSA) is a fatal neurodegenerative disease, and the pathogenesis is still quite challenging. Emerging evidence has shown that the brain-gut-microbiota axis served a pivotal role in neurological diseases; however, researches utilizing metagenomic sequencing to analyze the alteration in gut microbiota of MSA patients were quite rare. Here, we carried out metagenomic sequencing in feces of 15 MSA patients and 15 healthy controls, to characterize the alterations in gut microbial composition and function of MSA patients in mainland China. The results showed that gut microbial community of MSA patients was significantly different from healthy controls, characterized by increased genus Akkermansia and species Roseburia hominis, Akkermansia muciniphila, Alistipes onderdonkii, Streptococcus parasanguinis, and Staphylococcus xylosus, while decreased genera Megamonas, Bifidobacterium, Blautia, and Aggregatibacter and species Bacteroides coprocola, Megamonas funiformis, Bifidobacterium pseudocatenulatum, Clostridium nexile, Bacteroides plebeius, and Granulicatella adiacens. Further, functional analysis based on the KEGG database revealed aberrant functional pathways in fecal microbiome of MSA patients. In conclusion, our findings provided evidence for dysbiosis in gut microbiota of Chinese MSA cohorts and helped develop new testable hypotheses on pathophysiology of MSA.
Insights
Gut microbiota is altered in Multiple System Atrophy (MSA) patients. This study identified specific bacterial changes, offering new insights into the gut-brain axis in this neurodegenerative disease.
Area of Science:
- Neuroscience
- Microbiology
- Gastroenterology
Background:
- Multiple System Atrophy (MSA) is a fatal neurodegenerative disease with challenging pathogenesis.
- The brain-gut-microbiota axis is increasingly recognized for its role in neurological disorders.
- Research on gut microbiota alterations in MSA using metagenomic sequencing is limited.
Purpose of the Study:
- To characterize gut microbial composition and function in Chinese MSA patients.
- To identify specific microbial taxa and pathways associated with MSA.
- To explore the role of the gut-brain axis in MSA pathophysiology.
Main Methods:
- Metagenomic sequencing of fecal samples from 15 MSA patients and 15 healthy controls.
- Analysis of microbial community composition and functional pathways using the KEGG database.
Main Results:
- Significant differences in gut microbial communities between MSA patients and healthy controls.
- Increased abundance of genera *Akkermansia* and species *Roseburia hominis*, *Akkermansia muciniphila*, *Alistipes onderdonkii*, *Streptococcus parasanguinis*, and *Staphylococcus xylosus* in MSA patients.
- Decreased abundance of genera *Megamonas*, *Bifidobacterium*, *Blautia*, *Aggregatibacter* and species *Bacteroides coprocola*, *Megamonas funiformis*, *Bifidobacterium pseudocatenulatum*, *Clostridium nexile*, *Bacteroides plebeius*, and *Granulicatella adiacens* in MSA patients.
- Aberrant functional pathways identified in the fecal microbiome of MSA patients.
Conclusions:
- Evidence of gut microbiota dysbiosis in Chinese MSA cohorts.
- Findings support the involvement of the gut-brain axis in MSA.
- This study provides a foundation for developing new hypotheses on MSA pathophysiology.
Related Concept Videos
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
What is Monogastric Digestion?
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Fungal Phylum Microsporidia
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:

